Denil Nanji Shekhat - 01 Oct 2025 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Denil Shekhat
Issuer symbol
MIRA
Transactions as of
01 Oct 2025
Net transactions value
+$30,210
Form type
4
Filing time
03 Oct 2025, 20:00:18 UTC
Previous filing
10 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shekhat Denil Nanji Director C/O MIRA PHARMACEUTICALS, INC., 1200 BRICKELL AVE. SUITE 1950 #1183, MIAMI /s/ Denil Shekhat 03 Oct 2025 0002016605

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRA Common Stock Award $30,210 +22,378 $1.35 22,378 01 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.